Trial Profile
Retrospective cohort study investigating 4-year effectiveness and safety of tenofovir monotherapy treatment in chronic hepatitis B patients with or without cirrhosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 19 Dec 2015 New trial record